Nabbanja launches first ever Pathogen Bioscience Industrial Park
NAKASONGOLA, March 4, 2025 – Prime Minister Robinah Nabbanja has launched Uganda’s first-ever Pathogen Economy Bioscience Park, calling for concerted efforts to revolutionise the country’s biomedical sector.
The 152-acre industrial park, located in Kakooge, Nakasongola district, aims to reduce Uganda’s reliance on biomedical imports while fostering economic growth.
The facility is intended to be a hub for innovation and research, thereby driving Uganda’s transformation into a knowledge-based economy.
Prime Minister Nabbanja described the launch as a significant step forward in advancing Uganda’s scientific capabilities.
She added that it reflects the country’s commitment to using science, technology, and innovation to spur economic growth, improve public health, and build a prosperous future for all Ugandans.
“This facility will not only enhance our healthcare system but also provide opportunities for scientists and researchers to develop life-saving innovations,” she emphasised.
The Prime Minister stated that the facility is expected to create 9,000 direct jobs for scientists, engineers, and technicians, as well as 80,000 indirect jobs in logistics, marketing, and contract manufacturing.
The facility will focus on tissue banking, medical organ production, and pharmaceutical advancements and research, positioning Uganda as a key player in regional and global medical research.
The project will also serve as a centre for technological innovation and a platform for medical research, addressing infrastructure challenges by improving access to essential utilities such as water and electricity in the area.
The facility is structured into five industrial zones, each dedicated to a specific area of bioscience and medical production.
This initiative brings Uganda in line with countries such as Kenya, which has made significant strides in bioscience investment and innovation. Kenya is home to the International Centre of Insect Physiology and Ecology [ICIPE], established in 1970 to respond to vector control and insect science research. The centre leads institutional research focusing on sustainable development through human, animal, plant, and environmental health.
Similar research and innovation facilities are located in Morocco and South Africa, while the United Kingdom has developed a thriving bioscience hub in Liverpool, excelling in vaccine development and infectious disease control and research.
In Uganda, the facility is expected to enhance the country’s capacity for local pharmaceutical manufacturing, reducing reliance on imported medical supplies and strengthening the national healthcare system. Once operational, the facility will place Uganda firmly on the global bioscience and medical research map, solidifying its position as a leader in Africa’s scientific and healthcare development.
Dr. Monica Musenero, Minister for Science, Technology, and Innovation, stated that the industrial park would reduce Uganda’s pharmaceutical import bill by 20 percent, saving the country over Shs 100 billion annually.
She further highlighted that the park’s economic impact is expected to be substantial, contributing 5 billion dollars to the country’s GDP and positioning Uganda as a leader in Africa’s biotech industry.
Prime Minister Nabbanja concluded by noting that the facility will also serve as a key training hub for students and researchers.
The park’s first investors, BioBio Tech, have already developed PCR diagnostic kits, saving Uganda over Shs 200 billion in import costs.
https://thecooperator.news/mps-ask-govt-to-establish-more-industrial-parks/
Buy your copy of thecooperator magazine from one of our country-wide vending points or an e-copy on emag.thecooperator.news
Views: 0
